Iron deficiency anemia coexists with cancer related anemia and adversely impacts quality of life

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Kanuri, Giridhar ^a   Sawhney, Ritica ^a   Varghese, Jeeva ^a   Britto, Madonna ^a   Shet, Arun ^a  

^a ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; FERRITIN; IRON;

ADULT; ADVERSE OUTCOME; ARTICLE; CANCER PATIENT; CANCER RELATED ANEMIA; CANCER SURVIVAL; CLINICAL ASSESSMENT TOOL; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; FEMALE; FERRITIN BLOOD LEVEL; FUNCTIONAL ASSESSMENT OF CANCER THERAPY ANEMIA TOOL; HEAD AND NECK CANCER; HUMAN; INFLAMMATION; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OVERALL SURVIVAL; PREVALENCE; PROSPECTIVE STUDY; QUALITY OF LIFE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; TERTIARY CARE CENTER;

EID: 84991632840     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0163817     Document Type: Article

References (34)

1. Ludwig H, Van Belle S, Barrett-Lee P, Birgegard G, Bokemeyer C, Gascon P, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. European journal of cancer. 2004; 40 (15):2293-306. doi: 10.1016/j.ejca.2004.06.019 PMID: 15454256.
2. Birgegard G, Aapro MS, Bokemeyer C, Dicato M, Drings P, Hornedo J, et al. Cancer-related anemia: pathogenesis, prevalence and treatment. Oncology. 2005; 68 Suppl 1:3-11. doi: 10.1159/000083128 PMID: 15855811.
3. Tchekmedyian NS. Anemia in cancer patients: significance, epidemiology, and current therapy. Oncology (Williston Park). 2002; 16(9 Suppl 10):17-24. PMID: 12380951.
4. Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer. 2001; 91(12):2214-21. PMID: 11413508.
5. Mercadante S, Gebbia V, Marrazzo A, Filosto S. Anaemia in cancer: pathophysiology and treatment. Cancer treatment reviews. 2000; 26(4):303-11. doi: 10.1053/ctrv.2000.0181 PMID: 10913385.
6. Glaspy J. The impact of epoetin alfa on quality of life during cancer chemotherapy: a fresh look at an old problem. Seminars in hematology. 1997; 34(3 Suppl 2):20-6. PMID: 9253780.
7. Demetri GD, Kris M, Wade J, Degos L, Cella D. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 1998; 16(10):3412-25. PMID: 9779721.
8. Cella D. Factors influencing quality of life in cancer patients: anemia and fatigue. Seminars in oncology. 1998; 25(3 Suppl 7):43-6. PMID: 9671330.
9. Ludwig H, Strasser K. Symptomatology of anemia. Seminars in oncology. 2001; 28(2 Suppl 8):7-14. PMID: 11395846.
10. Grotto HZ. Anaemia of cancer: an overview of mechanisms involved in its pathogenesis. Medical oncology. 2008; 25(1):12-21. doi: 10.1007/s12032-007-9000-8 PMID: 18188710.
11. Verdon F, Burnand B, Stubi CL, Bonard C, Graff M, Michaud A, et al. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. Bmj. 2003; 326(7399):1124. doi: 10.1136/bmj.326.7399.1124 PMID: 12763985.
12. George John SS, Akhila Lakshmikantha, Arun Shet, editor Distribution of cancer anemia and its treatment in a limited resource setting. NCRI Cancer Conferences; 2010; Liverpool.
13. WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. World Health Organization. 2011;(WHO/NMH/NHD/MNM/11.1)
14. Skikne BS, Punnonen K, Caldron PH, Bennett MT, Rehu M, Gasior GH, et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index. American journal of hematology. 2011; 86(11):923-7. doi: 10.1002/ajh.22108 PMID: 21812017.
15. Steegmann JL, Sanchez Torres JM, Colomer R, Vaz A, Lopez J, Jalon I, et al. Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish survey. Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2013; 15(6):477-83. doi: 10.1007/s12094-012-0953-5 PMID: 23263906.
16. Merlini L, Carteni G, Iacobelli S, Stelitano C, Airoldi M, Balcke P, et al. Anemia prevalence and treatment practice in patients with non-myeloid tumors receiving chemotherapy. Cancer management and research. 2013; 5:205-14. doi: 10.2147/CMAR.S45236 PMID: 23946669.
17. Verbeke N, Beguin Y, Wildiers H, Canon JL, Bries G, Bosly A, et al. High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008). Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. 2012; 20(1):23-8. doi: 10.1007/s00520-010-1045-0 PMID: 21107613.
18. Seshadri T, Prince HM, Bell DR, Coughlin PB, James PP, Richardson GE, et al. The Australian Cancer Anaemia Survey: a snapshot of anaemia in adult patients with cancer. The Medical journal of Australia. 2005; 182(9):453-7. PMID: 15865588.
19. Kitano T, Tada H, Nishimura T, Teramukai S, Kanai M, Nishimura T, et al. Prevalence and incidence of anemia in Japanese cancer patients receiving outpatient chemotherapy. International journal of hematology. 2007; 86(1):37-41. doi: 10.1532/IJH97.07040 PMID: 17675265.
20. Parikh PM BA. Cancer related Anemia - Guidelines for Developing Countries. Parikh PM BA, editor. Mumbai Elsevier; 2005.
21. India TNFHSN-o. The National Family Health Survey (NFHS-4) of India. 2015-16.
22. Aapro M, Osterborg A, Gascon P, Ludwig H, Beguin Y. Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO. 2012; 23(8):1954-62. doi: 10.1093/annonc/mds112 PMID: 22575608.
23. Goodnough LT, Nemeth E, Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood. 2010; 116(23):4754-61. doi: 10.1182/blood-2010-05-286260 PMID: 20826717.
24. Weiss G, Goodnough LT. Anemia of chronic disease. The New England journal of medicine. 2005; 352 (10):1011-23. doi: 10.1056/NEJMra041809 PMID: 15758012.
25. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997; 89(3):1052-7.PMID: 9028338.
26. Margetic S, Topic E, Ruzic DF, Kvaternik M. Soluble transferrin receptor and transferrin receptor-ferritin index in iron deficiency anemia and anemia in rheumatoid arthritis. Clinical chemistry and laboratory medicine: CCLM / FESCC. 2005; 43(3):326-31. doi: 10.1515/CCLM.2005.056 PMID: 15843240.
27. Thomas C, Thomas L. Anemia of chronic disease: pathophysiology and laboratory diagnosis. Laboratory hematology: official publication of the International Society for Laboratory Hematology. 2005; 11 (1):14-23. doi: 10.1532/LH96.04049 PMID: 15790548.
28. Zubrikhina GN, Blindar VN, Matveeva II. [Differential diagnosis of anemia in true and functional iron deficiency in patients with chronic diseases (malignant tumors)]. Terapevticheskii arkhiv. 2016; 88 (4):61-7. PMID: 27070165.
29. Lind M, Vernon C, Cruickshank D, Wilkinson P, Littlewood T, Stuart N, et al. The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. British journal of cancer. 2002; 86 (8):1243-9. doi: 10.1038/sj.bjc.6600247 PMID: 11953880.
30. Crawford J, Cella D, Cleeland CS, Cremieux PY, Demetri GD, Sarokhan BJ, et al. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer. 2002; 95(4):888-95. doi: 10.1002/cncr.10763 PMID: 12209734.
31. Auerbach M, Ballard H, Trout JR, McIlwain M, Ackerman A, Bahrain H, et al. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2004; 22(7):1301-7. doi: 10.1200/JCO.2004.08.119 PMID: 15051778.
32. Wasada I, Eguchi H, Kurita M, Kudo S, Shishida T, Mishima Y, et al. Anemia affects the quality of life of Japanese cancer patients. The Tokai journal of experimental and clinical medicine. 2013; 38(1):7-11. PMID: 23564569.
33. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. The New England journal of medicine. 2009; 361(25):2436-48. doi: 10.1056/NEJMoa0908355 PMID: 19920054.
34. Pinnix ZK, Miller LD, Wang W, D'Agostino R Jr, Kute T, Willingham MC, et al. Ferroportin and iron regulation in breast cancer progression and prognosis. Science translational medicine. 2010; 2 (43):43ra56. doi: 10.1126/scisignal.3001127 PMID: 20686179.